-Galla S Kiran Kumar,Bureau Chief Telagana (Andhra Pradesh)
Telangana IT and Industries Minister KTR said that the goal of doubling the value and jobs of the biology sector in the state by 2028 is moving ahead. At present there are four lakh jobs in this sector and the aim is to increase it to eight lakh in the next five years.
We are moving ahead with the same goal Minister KTR revealed the details of the Apple conference
in Hyderabad from 24th to 26th Bio Asia conference for the first time – Hyderabad
come onTelangana IT and Industries Minister KTR said that the goal of doubling the value and jobs of the biology sector in the state by 2028 is moving ahead. At present there are four lakh jobs in this sector and the aim is to increase it to eight lakh in the next five years. In 2021, the net worth of life sciences companies in the vicinity of Hyderabad is 50 billion dollars, and plans have been made to increase this to 100 billion dollars by 2028. He said that ‘Apple’ company is participating for the first time in the 20th Bio Asia Conference to be held from 24th to 26th of this month in Hyderabad with the slogan ‘Advancing for One: Shaping Next Generation Humanized Healthcare’. He said that while Switzerland was the partner country for the conference last year, this year UK is acting. In the context of the Bio Asia Conference, Tuesday, IT, Industries Department Principal Secretary Jayesh Ranjan along with Telangana Life Sciences Director Shakti Nagappan spoke to KTR reporters. Telangana has become the hub of the world in the field of biology. We are producing 900 crore vaccine doses per year from Ikan. This is 35 percent of the vaccines produced worldwide. Next year we are going to reach the production capacity of 1,400 crore doses (50%). At present the vaccines produced here are being exported to more than 150 countries. 14 thousand acres are available in Hyderabad Pharmacity. It will emerge as the largest pharma cluster in the world. 30 lakh square feet of construction has already been completed in Genome Valley. Construction of another 20 lakh square feet is in progress. Telangana has become the hub of the world in the field of biology. We are producing 900 crore vaccine doses per year from Ikan. This is 35 percent of the vaccines produced worldwide. Next year we are going to reach the production capacity of 1,400 crore doses (50%). At present the vaccines produced here are being exported to more than 150 countries. 14 thousand acres are available in Hyderabad Pharmacity. It will emerge as the largest pharma cluster in the world. 30 lakh square feet of construction has already been completed in Genome Valley. Construction of another 20 lakh square feet is in progress. Telangana has become the hub of the world in the field of biology. We are producing 900 crore vaccine doses per year from Ikan. This is 35 percent of the vaccines produced worldwide. Next year we are going to reach the production capacity of 1,400 crore doses (50%). At present the vaccines produced here are being exported to more than 150 countries. 14 thousand acres are available in Hyderabad Pharmacity. It will emerge as the largest pharma cluster in the world. 30 lakh square feet of construction has already been completed in Genome Valley. Construction of another 20 lakh square feet is in progress. At present the vaccines produced here are being exported to more than 150 countries. 14 thousand acres are available in Hyderabad Pharmacity. It will emerge as the largest pharma cluster in the world. 30 lakh square feet of construction has already been completed in Genome Valley. Construction of another 20 lakh square feet is in progress. At present the vaccines produced here are being exported to more than 150 countries. 14 thousand acres are available in Hyderabad Pharmacity. It will emerge as the largest pharma cluster in the world. 30 lakh square feet of construction has already been completed in Genome Valley. Construction of another 20 lakh square feet is in progress.
We are continuing the reign of 19 years
The organization of the Bio Asia conference, which started 19 years ago in the united Andhra Pradesh, continues even after the formation of the state. So far, we have invited the chairmen, CEOs, scientists and Nobel laureates of famous companies to the conference and made them participate in the discussions. About 100 organizations participated. We have organized more than 20 thousand partnership meetings. So far we have been able to attract investments of Rs.25 thousand crores. We have signed more than 250 bilateral agreements.
We have prepared more than 30 policy documents related to quality products and recommended them to the central governments in power at the time as a conference venue.
Focus on quality products
Importing certain types of products is better than manufacturing them. For example, masks and gloves are cheap if they are imported from China. That is why we have focused on improving the opportunities for the production of quality goods at reasonable prices in the state.
The number of representatives is increasing
Bio Asia is playing a key role in increasing investment in India. The number of delegates attending the BioAsia Conference is steadily increasing every year. In 2021, 2,500 people from 95 countries participated during the outbreak of Covid. Switzerland, Norway, Thailand, Korea, Argentina, Spain, UK, Germany, South Africa and other countries participated and sent their representatives. The state has established relations with the pharma and life sciences sectors in the respective countries. For example, recently a Memorandum of Understanding was signed with the ‘Flanders Investment, Trade (FIT)’ region in Belgium. The Genome Valley Excellence Award is presented annually to those who have made outstanding contributions in biology. This year we are presenting it to Acharya Robert Langer. He especially worked on mRNA technology.
Life Sciences University soon
We have entered into an MoU with King’s College London to establish a Life Sciences University in Pharma City. We have discussed with Education Minister Sabitha Indra Reddy to set up the medical college to be established in Rangareddy district and the associated hospital in Pharma City. Nursing and paramedical colleges will also come up. The opportunities for experiments are increasing,” said KTR.
Most of the FDA approved pharma companies are here
The state has the highest (214) pharma companies certified by the US Food and Drug Administration (FDA) . After Telangana, the highest number of FDA certified companies (189) is in New Jersey in America. The Medical Devices Park in Sultanpur houses the world’s largest manufacturer of stents. Glasses used in Telangana are made there.
A selection of five seeds
As part of the Bio Asia conference, many seeds will be competing in the biotech and life sciences section. will display their products. Out of a total of 400 participants, 75 organizations were initially selected. From this we will select five for the final list. They will be given a cash award and an opportunity to speak for five minutes each at the conference.
Soon mRNA vaccine center
Soon we are going to set up a center in life sciences in the state in association with the World Economic Forum. Under the auspices of the World Health Organization, mRNA (Messenger Ribonucleic Acid) vaccination center will be set up in Hyderabad. This is a proof of how important Telangana is playing in the field of pharma and life sciences. After the formation of the state, we have showcased the strengths of bio and life sciences systems on international platforms. As a result, a leading pharma device manufacturing company like Medtron has set up its second largest premises in Telangana for research, production and innovation.
